Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Leidos, Atlanta, Georgia.
Infect Control Hosp Epidemiol. 2022 Jan;43(1):12-25. doi: 10.1017/ice.2021.362. Epub 2021 Sep 3.
To determine the impact of the coronavirus disease 2019 (COVID-19) pandemic on healthcare-associated infection (HAI) incidence in US hospitals, national- and state-level standardized infection ratios (SIRs) were calculated for each quarter in 2020 and compared to those from 2019.
Central-line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated events (VAEs), select surgical site infections, and Clostridioides difficile and methicillin-resistant Staphylococcus aureus (MRSA) bacteremia laboratory-identified events reported to the National Healthcare Safety Network for 2019 and 2020 by acute-care hospitals were analyzed. SIRs were calculated for each HAI and quarter by dividing the number of reported infections by the number of predicted infections, calculated using 2015 national baseline data. Percentage changes between 2019 and 2020 SIRs were calculated. Supporting analyses, such as an assessment of device utilization in 2020 compared to 2019, were also performed.
Significant increases in the national SIRs for CLABSI, CAUTI, VAE, and MRSA bacteremia were observed in 2020. Changes in the SIR varied by quarter and state. The largest increase was observed for CLABSI, and significant increases in VAE incidence and ventilator utilization were seen across all 4 quarters of 2020.
This report provides a national view of the increases in HAI incidence in 2020. These data highlight the need to return to conventional infection prevention and control practices and build resiliency in these programs to withstand future pandemics.
确定 2019 年冠状病毒病(COVID-19)大流行对美国医院医源性感染(HAI)发生率的影响,计算了 2020 年每一季度的全国和州级标准化感染比(SIR),并与 2019 年进行了比较。
对 2019 年和 2020 年向国家医疗保健安全网络报告的急性护理医院报告的中央导管相关血流感染(CLABSI)、导管相关尿路感染(CAUTI)、呼吸机相关事件(VAE)、特定手术部位感染以及艰难梭菌和耐甲氧西林金黄色葡萄球菌(MRSA)菌血症实验室鉴定事件进行分析。通过将报告的感染数除以使用 2015 年国家基线数据计算的预测感染数,计算了每种 HAI 和每一季度的 SIR。计算了 2019 年和 2020 年 SIR 之间的百分比变化。还进行了支持性分析,例如评估 2020 年与 2019 年相比设备使用率的变化。
2020 年,全国 CLABSI、CAUTI、VAE 和 MRSA 菌血症的 SIR 显著增加。SIR 的变化因季度和州而异。CLABSI 的增幅最大,2020 年所有四个季度的 VAE 发病率和呼吸机使用率均显著增加。
本报告提供了 2020 年 HAI 发生率增加的全国性观点。这些数据强调了需要恢复常规感染预防和控制措施,并增强这些计划的弹性,以抵御未来的大流行。